Since patient samples inevitably contain a mix of leukemic and nonleukemic cells (Supplemental Table 12), and contaminating nonleukemic cells contain CBFB but not CBFB::MYH11, the ratio of 4.5:1 may underestimate the true ratio in AML cells. This evidence concerns the gene CBFB and acute myeloid leukemia.